Yesterday when we read about the agreement between Dexcom and The University of Virginia our initial reaction was what took so long. Not to be redundant but we have consistently stated that CGM has wide ranging applications beyond diabetes. Although this agreement is diabetes focused it continues a trend that Abbott has also joined with their sensor for elite athletes. Dexcom and Abbott both understand that for sensor usage to keep growing and grow beyond diabetes, users have to know what to do with all the damn data. They need to know the same thing patients with diabetes need to . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.